These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16488047)

  • 21. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-evaluation of randomized controlled trials of lithium monotherapy.
    Severus WE; Kleindienst N; Greil W
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):519-20; author reply 521. PubMed ID: 17042892
    [No Abstract]   [Full Text] [Related]  

  • 23. Lithium specificity in bipolar illness: a classic agent for the classic disorder.
    Gershon S; Chengappa KN; Malhi GS
    Bipolar Disord; 2009 Jun; 11 Suppl 2():34-44. PubMed ID: 19538684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factorial design approach to evaluate interactions between electrically assisted enhancement and skin stripping for delivery of tacrine.
    Hirsch AC; Upasani RS; Banga AK
    J Control Release; 2005 Mar; 103(1):113-21. PubMed ID: 15710505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.
    Marro D; Kalia YN; Delgado-Charro MB; Guy RH
    Pharm Res; 2001 Dec; 18(12):1709-13. PubMed ID: 11785690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling.
    Leboulanger B; Fathi M; Guy RH; Delgado-Charro MB
    Pharm Res; 2004 Jul; 21(7):1214-22. PubMed ID: 15290862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive lithium monitoring.
    Préat V
    Clin Chem; 2004 Nov; 50(11):1966-7. PubMed ID: 15502077
    [No Abstract]   [Full Text] [Related]  

  • 29. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
    Torrent C; Amann B; Sánchez-Moreno J; Colom F; Reinares M; Comes M; Rosa AR; Scott J; Vieta E
    Acta Psychiatr Scand; 2008 Jul; 118(1):4-18. PubMed ID: 18498432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transport numbers in transdermal iontophoresis.
    Mudry B; Guy RH; Delgado-Charro MB
    Biophys J; 2006 Apr; 90(8):2822-30. PubMed ID: 16443654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
    Patel SR; Zhong H; Sharma A; Kalia YN
    Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of lithium on bipolar disorder.
    Malhi GS
    Bipolar Disord; 2009 Jun; 11 Suppl 2():1-3. PubMed ID: 19538680
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of amino acid sequence on transdermal iontophoretic peptide delivery.
    Schuetz YB; Naik A; Guy RH; Kalia YN
    Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive monitoring of phenytoin by reverse iontophoresis.
    Leboulanger B; Guy RH; Delgado-Charro MB
    Eur J Pharm Sci; 2004 Aug; 22(5):427-33. PubMed ID: 15265512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.
    Abla N; Naik A; Guy RH; Kalia YN
    J Control Release; 2005 Nov; 108(2-3):319-30. PubMed ID: 16169627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of receptor solution specific conductivity on iontophoresis of tetracaine hydrochloride.
    Xu DH; Hu QH; Liang WQ
    Yao Xue Xue Bao; 2004 Feb; 39(2):144-8. PubMed ID: 15127625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On being bipolar without being bipolar.
    Goldberg J
    J Psychopharmacol; 2008 Jun; 22(4):402-3; discussion 408. PubMed ID: 18635717
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amikacin reverse iontophoresis: optimization of in vitro extraction.
    Marra F; Nicoli S; Padula C; Santi P
    Int J Pharm; 2013 Jan; 440(2):216-20. PubMed ID: 22824514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.